-month period ended September 30, 2017 and the nine-month period ended September 30, 2018, respectively. The figures represent a period-on-period increase of 20.55% due mainly to an activating new hospital
products from China. The proportion of revenue from sales increase by Baht 23 million and as a result of the gross profit margin growth to 16%. Sales from selling food and beverages Revenue from sales
from payments. While cash and cash equivalents increased by 71.28 million baht. In terms of non-current assets, an increase of 96.92 million baht, mainly due to an increase in the right to use assets of
% YoY as a result of TTTBB EBITDA contribution and business growth. The net profit reported at Bt17,028mn, an increase of 22% YoY driven by operating performance and profit sharing from 3BBIF. SIM
EBITDA increased by 21% YoY as a result of TTTBB EBITDA contribution and business growth. The net profit reported at Bt17,028mn, an increase of 22% YoY driven by operating performance and profit sharing
of the Newly Issued Ordinary Shares of the Company through a Private Placement which is a Connected Transaction, Capital Reduction, Capital Increase, Entering into the Right to Sell Advertising Media
subsidiaries for 1Q21 at Baht 1,463 million, an increase of 32.0% from the previous quarter. When comparing to 1Q20, net profit decline slightly by 1.4%. The consolidated comprehensive income for 1Q21 totaled
revenue growth. In addition, the increase of cash and cash equivalents due to profit of the Company. However, there was a decrease of investment held as available- for-sale by THB 41.91 Million due to
development and sustainable growth in the future. While its business partners and business alliance members might be parties with possible conflict of interests, nevertheless, The Board of Directors might find